CardioMEMS HF System Study for Heart Failure
This study is looking at how well the CardioMEMS HF System helps people with heart failure in real-world settings. The CardioMEMS HF System is a device that measures pressure in your pulmonary artery (the main artery from your heart to your lungs). Researchers want to see if using this system to guide heart failure treatment improves long-term health, specifically by reducing how often people need to be hospitalized for heart failure. You might be able to join if you are 18 or older, have a CardioMEMS pressure sensor implanted, and have a history of acute decompensated heart failure or heart failure-related congestion. The study aims to enroll 1000 participants, but its current status is unclear.
- Study design
- This is an observational study comparing heart failure patients managed with the CardioMEMS HF system to a group managed without it. It is not specified if this study is randomized or blinded.
- What's involved
- Not specified in the trial record.
- Compensation
- Not stated in the trial record.
- Follow-up
- The study will assess outcomes for 2 years.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
CardioMEMS HF System Coverage With Evidence Development Study
At a glance
Conditions
NCT06779552
Where you'd take part
This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.
Abbott
Pleasanton, Californiastudy coordinator listed
Recruiting
Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- HF Hospitalization Rate.2 years
Compare HF hospitalization rate between the treatment and control groups.